Optalert's new Owl Eye app tests for signs of sleep issues.
The Next Threshold: Health Screening
Optalert Moves Beyond Drowsiness
Optalert is identifying breakthrough biomarkers of neurological conditions and other sleep disorders. Beyond drowsiness detection, its research team is unlocking the ability to detect a range of medical conditions.
- Alzheimer’s
- Epilepsy
- Parkinson’s
- Traumatic brain injury (TBI)
- Other neurological disorders
Pioneered by Optalert, the field of blepharometry involves analysis of eyelid movements. These are a window into a person’s cognitive state and let researchers identify the presence of numerous conditions. Optalert is making bold strides in testing for sleep disorders, identifying stages of neurodegeneration, and monitoring response to treatment.
All in the blink of an eye.